TMPRSS2 and neoplasm: Our data show that enzalutamide inhibited the growth of VCaP cells expressing TMPRSS2-ERG fusion genes, but when ERG factor was stably knocked down with lentiviral shERG RNA, tumor growth inhibition occurred at lesser extent.